Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

SIMPLE SUMMARY: Uterine serous cancer (USC) is an aggressive form of endometrial cancer. USC constitutes less than 10% of endometrial cancer cases but is responsible for up to 40% of endometrial cancer deaths. Response to standard platinum and taxane therapy is modest, particularly in the recurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Toboni, Michael D., Lomonosova, Elena, Bruce, Shaina F., Tankou, Jo’an I., Mullen, Mary M., Schab, Angela, Oplt, Alyssa, Noia, Hollie, Wilke, Danny, Kuroki, Lindsay M., Hagemann, Andrea R., McCourt, Carolyn K., Thaker, Premal H., Powell, Matthew A., Khabele, Dineo, Mutch, David G., Fuh, Katherine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656641/
https://www.ncbi.nlm.nih.gov/pubmed/34884986
http://dx.doi.org/10.3390/cancers13235877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656641/
https://www.ncbi.nlm.nih.gov/pubmed/34884986
http://dx.doi.org/10.3390/cancers13235877

Ejemplares similares